U.S., June 24 -- ClinicalTrials.gov registry received information related to the study (NCT07662369) titled 'CD45RA-depleted DLI for the Treatment of Refractory/Persistent Viral Infections After Haploidentical Transplantation' on June 16.
Brief Summary: The goal of this clinical trial is to learn whether giving patients special donor immune cells (called "CD45RA Depleted DLI") can help treat viral infections that have not improved with standard antiviral drugs. These infections occur after a stem cell transplant. The study will also look at the safety of this treatment.
Study Start Date: June 01
Study Type: INTERVENTIONAL
Condition:
Hematologic Malignancy
Haplo-identical HCT
Intervention:
BIOLOGICAL: CD45RA depleted donor lymphocyte ...